基础医学与临床 ›› 2010, Vol. 30 ›› Issue (9): 930-934.

• 研究论文 • 上一篇    下一篇

心肌钻孔结合肝素化bFGF缓释支架植入促进猪急性心肌梗死后心肌干细胞再生

张光伟 刘晓程 史蓉芳 赵晓斌 刘天军 吕丰   

  1. 天津医科大学心血管病临床学院 天津医科大学心血管病临床学院
  • 收稿日期:2009-11-17 修回日期:2009-12-19 出版日期:2010-09-05 发布日期:2010-09-05
  • 通讯作者: 刘晓程

Transmyocardial Drilling Revascularization Combined with Heparinized bFGF-Incorporating Stent Promotes Regeneration of Myocardium after Pig Acute Myocardial Infarction

Guang-wei ZHANG, Xiao-cheng LIU, Rong-fang SHI, Xiao-bin ZHAO, Tian-jun LIU, Feng LV   

  1. Tianjin Medical University Cardiovascular Clinical College Tianjin Medical University Cardiovascular Clinical College
  • Received:2009-11-17 Revised:2009-12-19 Online:2010-09-05 Published:2010-09-05
  • Contact: Xiao-cheng LIU,

摘要: 目的 观察心肌钻孔结合肝素化bFGF缓释支架植入在急性心肌梗死后心肌细胞再生中的作用。方法 结扎冠脉前降支制作猪急性心梗模型,然后随机分为对照组和治疗组(均6只)。治疗组,于心梗区用自制高速钻孔器由心外膜打2个直径为3.5mm透壁孔道,每孔内植入一枚肝素化bFGF缓释支架。术后每周2次静脉注射5-溴脱氧尿嘧啶核苷(BrdU) 250mg,用以标记DNA复制。用RT-PCR观察基质细胞衍生因子-1(SDF-1) mRNA表达,心肌灌注核素显像评价心肌灌注、心功能变化,免疫组化检测新生心肌。结果 治疗后6周,治疗组SDF-1 mRNA表达为4.02±0.31,显著高于对照组的1.63±0.21(P<0.001);治疗前后灌注质量缺损百分率的差值为-3.22%±0.46%,明显低于对照组的2.83%±0.31%(P<0.001);BrdU 的A值为1639±105 pixels/hpf,显著高于对照组的240±53 pixels/hpf(P<0.001);存活心肌面积的A值为94118±4476 pixels/hpf,显著高于对照组的36345±3714 pixels/hpf(P<0.001);左室射血分数为61%±4%,显著高于对照组的49%±3%(P<0.001)。结论 心肌钻孔结合肝素化bFGF缓释支架植入可能成为心肌梗死后心肌再生治疗的有效方法。

关键词: 心肌梗死, 心肌细胞, 再生, 支架, 碱性成纤维细胞生长因子。

Abstract: Objective To investigate the effect of transmyocardial drilling revascularization combined with heparinized bFGF-incorporating degradable tubular stent implantation (TMDRSI) on myocardial regeneration after acute myocardial infarction. Methods After the mid third of left anterior descending (LAD) was ligated, miniswine were grouped into control group and treatment group (n=6 each group). In treatment group, two transmural channels with 3.5 mm in diameter were established by using a self-made drilling device, followed by implantation of two stents into the channels. All animals received 5-bromo-2-deoxyuridine (BrdU) 250 mg IV twice a week post-operatively, to label cells undergoing DNA replication. Expression of stromal cell-derived factor 1 (SDF-1) was determined with RT-PCR. Myocardial perfusion and left ventricular ejection fraction (LVEF) were evaluated by 99m Tc-MIBI Myocardial Perfusion Imaging. Histological and morphological analyses were used to observe myocardial regeneration. Results At 6 weeks post-treatment, expression of SDF-1 significantly upregulated in treatment group (4.02±0.31), compared with control group (1.63±0.21, P<0.001). Change of Mass defect percent significantly decreased in treatment group (-3.22%±0.46%), compared with control group (2.83%±0.31%, P<0.001). A value of BrdU in treatment group (1639±105 pixels/hpf) was more than that in control group (240±53 pixels/hpf, P<0.001). A value of area of viable myocardium (94118±4476 pixels/hpf) in treatment group was higher than that in control group (36345±3714 pixels/hpf, P<0.001). LVEF was significantly improved in treatment group (61%±4%), compared with control group (49%±3%, P<0.001). Conclusions TMDRSI may be a new method for the regeneration treatment of acute myocardial infarction.

Key words: Myocardial infarction, Myocardium, Regeneration, Stent, Fibroblast growth factor 2.

中图分类号: